Want to read Slashdot from your mobile device? Point it at m.slashdot.org and keep reading!

 


Forgot your password?
Close
typodupeerror
Google

Honeycomb To Require Dual-Core Processor 177

Posted by timothy from the expand-the-requirements dept.
adeelarshad82 writes "According to managing director of Korean consumer electronics firm Enspert, Google's new Android Honeycomb tablet OS will require a dual-core ARM Cortex-A9 processor to run properly. That means that many existing Android tablets will not be upgradeable to Honeycomb, as they lack the processor necessary to meet the spec. Currently, Nvidia's Tegra 2 platform is the only chipset in products on the market to include a Cortex-A9, although other manufacturers have said they're moving to the new processor architecture for 2011 products."
Security

Journal Journal: Your Kids Could be Exposing Your Files on the Net

Journal by Alien54
Your kids could be exposing all of your confidential computer files to the entire world. WFXT (Fox 25 TV in Boston) has a video report on kids unwisely changing the sharing options in many P2P software packages, often sharing the entire hard drive without their parent's knowledge. After that, they are just a simple search from trouble. As
The Internet

Journal Journal: ISP pulls the plug on isohunt, podtropolis, and torrentbox.

Journal by spiralwebs
As seen on isohunt.com: " Update, Jan. 16, 2007 Lawyers from our primary ISP decided to pull our plug without any advance notice, as of 14:45 PST. No doubt related to our lawsuit brought by the MPAA, but we don't have more information at this time until people responsible comes to work tomorrow. We will be back in operation once we sort out this mess with our ISP, or we get new hardware ready from our new ISP. Sit back and enjoy the rest of the internet in the mean time, while it last. For your
Patents

Submission + - Cancer Figher May Not Get Chance Due to No Patent

Submitted by theshowmecanuck
theshowmecanuck writes: In a recent study, researchers at the University of Alberta Department of Medicine have shown that an existing small, relatively non-toxic non-patented molecule, dichloroacetate (DCA), "causes regression in several cancers, including lung, breast, and brain tumors".
"But there's a catch: the drug isn't patented, and pharmaceutical companies may not be interested in funding further research if the treatment won't make them a profit."
DCA is currently used to treat mitochondrial diseases in children. Mitochondria, which are the metabolic power houses of cells, and which also regulate cell death, are damaged in cancerous cells. This gives the cancerous cells an advantage over normal cells and helps protect them against chemotherapy. DCA seems to be able to correct the damage, something that was not thought possible before, causing tumour growth to slow. It doesn't seem to affect normal cells. It has been tested in test tubes and animal subjects. A link to another site in case of slashdotting.

Slashdot Top Deals

The difference between reality and unreality is that reality has so little to recommend it. -- Allan Sherman

Close